Literature DB >> 18829525

SCL/TAL1 interrupting locus derepresses GLI1 from the negative control of suppressor-of-fused in pancreatic cancer cell.

Kenji Kasai1, Shingo Inaguma, Akiko Yoneyama, Kazuhiro Yoshikawa, Hiroshi Ikeda.   

Abstract

As a physically binding protein of GLI1 transcription factor, Suppressor-of-Fused (SUFU) has been placed in the center of negative regulation of Hedgehog (Hh) signaling. SUFU tethers GLI1 in cytoplasm, and in some circumstances, it moves into the nucleus in association with GLI1, leading to the suppression of GLI1 target gene expression by recruiting a corepressor complex. The activated transcriptional function of GLI1 is important for cellular proliferation in a variety of human cancers. However, it has not been revealed how GLI1 is derepressed from SUFU-mediated suppression. Here, we show SCL/TAL1 interrupting locus (SIL) product, a cytoplasmic protein overexpressed in pancreatic ductal adenocarcinoma (PDA), is responsible for the derepression of GLI1. We found SIL associated with the carboxyl terminus of SUFU, one of two distinct GLI1-binding domains, and this association was responsible for cytoplasmic tethering of SUFU. Overexpressed SIL attenuated SUFU-mediated cytoplasmic tethering and target gene suppression of GLI1. Knockdown of SIL in PDA cells conversely induced the nuclear accumulation of SUFU in association with GLI1 and the transcriptional suppression of GLI1 target genes. Importantly, we also showed that oncogenic K-RAS, and not Sonic hedgehog, enhanced the SIL association with the amino-terminus of SUFU, the other GLI1-binding domain that led to further increase of nuclear translocation of GLI1. These results uncover the role of SIL in derepressing GLI1 from the negative control of SUFU, which is a crucial step for activating Hh signaling in cancer cells.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18829525     DOI: 10.1158/0008-5472.CAN-07-6661

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  28 in total

1.  DYRK1B-dependent autocrine-to-paracrine shift of Hedgehog signaling by mutant RAS.

Authors:  Matthias Lauth; Asa Bergström; Takashi Shimokawa; Ulrica Tostar; Qianren Jin; Volker Fendrich; Carmen Guerra; Mariano Barbacid; Rune Toftgård
Journal:  Nat Struct Mol Biol       Date:  2010-05-30       Impact factor: 15.369

2.  Identifying protein-protein interaction sites using peptide arrays.

Authors:  Hadar Amartely; Anat Iosub-Amir; Assaf Friedler
Journal:  J Vis Exp       Date:  2014-11-18       Impact factor: 1.355

3.  Functional expression of SCL/TAL1 interrupting locus (Stil) protects retinal dopaminergic cells from neurotoxin-induced degeneration.

Authors:  Jingling Li; Ping Li; Aprell Carr; Xiaokai Wang; April DeLaPaz; Lei Sun; Eric Lee; Erika Tomei; Lei Li
Journal:  J Biol Chem       Date:  2012-11-19       Impact factor: 5.157

4.  Identification of signature genes for detecting hedgehog signaling activation in gastric cancer.

Authors:  Ling Yang; Shuhong Huang; Yuehong Bian; Xiaoli Ma; Hongwei Zhang; Jingwu Xie
Journal:  Mol Med Rep       Date:  2010 May-Jun       Impact factor: 2.952

Review 5.  Hedgehog signaling in skin cancers.

Authors:  Chengxin Li; Sumin Chi; Jingwu Xie
Journal:  Cell Signal       Date:  2011-03-17       Impact factor: 4.315

Review 6.  Context-dependent regulation of the GLI code in cancer by HEDGEHOG and non-HEDGEHOG signals.

Authors:  Barbara Stecca; Ariel Ruiz i Altaba
Journal:  J Mol Cell Biol       Date:  2010-01-17       Impact factor: 6.216

7.  Transcription of the SCL/TAL1 interrupting Locus (Stil) is required for cell proliferation in adult Zebrafish Retinas.

Authors:  Lei Sun; Ping Li; Aprell L Carr; Ryne Gorsuch; Clare Yarka; Jingling Li; Michael Bartlett; Delaney Pfister; David R Hyde; Lei Li
Journal:  J Biol Chem       Date:  2014-01-27       Impact factor: 5.157

8.  Overexpression of Gli1 in cancer interstitial tissues predicts early relapse after radical operation of breast cancer.

Authors:  Ying-Hua Li; Hai-Feng Gao; Yan Wang; Fang Liu; Xiao-Feng Tian; Yang Zhang
Journal:  Chin J Cancer Res       Date:  2012-12       Impact factor: 5.087

9.  Clinical characterization of individuals with deletions of genes in holoprosencephaly pathways by aCGH refines the phenotypic spectrum of HPE.

Authors:  Jill A Rosenfeld; Blake C Ballif; Donna M Martin; Arthur S Aylsworth; Bassem A Bejjani; Beth S Torchia; Lisa G Shaffer
Journal:  Hum Genet       Date:  2010-04       Impact factor: 4.132

Review 10.  Primary microcephaly: do all roads lead to Rome?

Authors:  Gemma K Thornton; C Geoffrey Woods
Journal:  Trends Genet       Date:  2009-10-21       Impact factor: 11.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.